To Help Patients, Reform The Drug Pricing System Don't Impose Price Controls

Beneficial drug reforms remove the disincentives that plague the supply chain. Alternatively, drug price controls, such as the Pelosi bill, impose unconscionable costs and fail to fix the problems of the drug supply chain, all while failing to address the health care affordability crisis.